Memorial Sloan-Kettering Cancer Center

/Home/Leukemia Healthcare and Treatment Centers/Leukemia Health Care and Treatment Centers-US/New York Leukemia Healthcare and Treatment Centers

Memorial Sloan-Kettering Cancer Center

1275 York Avenue
New York, NY 10065

800-525-2225

Leukemias

Leukemia develops when a blood cell undergoes a transformation into a malignant cell -- one capable of uncontrolled growth. Chronic lymphocytic leukemia and acute myelogenous leukemia are the most common forms in adults.

At Memorial Sloan-Kettering, we offer the best possible clinical care as part of an interdisciplinary team approach. Our leukemia experts continually improve standards of care through clinical research.

In this section you can find information about our expertise in treating adults with leukemia, our services, and our research.

For information about our services for children with leukemia, please visit Pediatric Leukemias.

Our Approach & Expertise

Our leukemia team offers the most effective and advanced treatments available.

Because each physician is also an investigator in his or her field, they are very familiar with the latest discoveries and research studies related to the care of leukemia patients. They may suggest that a patient be offered the opportunity to participate in a clinical trial if they feel there is a good chance for an improved outcome. We have many studies under way that incorporate investigational treatment approaches for newly diagnosed and relapsed acute and chronic myelogenous and lymphocytic leukemias.

Our researchers are developing ways to make blood and bone marrow transplantation more widely available. In most centers, a marrow transplant from a normal donor is considered only if a matched relative is available for marrow donation. However, Memorial Sloan-Kettering is engaged in a program to evaluate marrow and cord blood transplants from matched unrelated donors. Memorial Sloan-Kettering has also pioneered the development of T-cell-depleted allogeneic transplants and donor lymphocyte infusions, which permit matched relatives (such as a patient's parent or child) to serve as donors, and thereby extend transplants to many more patients who require them.

We believe that treating the whole person, not just the disease, is the best for patients and family members.

At Memorial Sloan-Kettering, we offer a broad range of emotional support programs designed to help patients and family members cope with the range of issues related to life during and after cancer treatment.

©2009 Memorial Sloan-Kettering Cancer Center